FGFR4 and glioblastoma: Also the FAK inhibitor defactinib, targeting focal adhesion-related integrin downstream signaling, was hyperactive in FGFR4-KD(K504M) subclones (Additional File 1: Figure S9I + J), suggesting cooperation between FGFR4 and integrin-mediated signals promoting GBM cell survival.